Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1-infected Individuals
Phase of Trial: Phase 0
Latest Information Update: 08 May 2017
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 08 Mar 2016 Planned End Date changed from 1 Jul 2017 to 1 Jul 2021, as reported by ClinicalTrials.gov record.
- 08 Mar 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2020, as reported by ClinicalTrials.gov record.
- 10 Jun 2015 Planned number of patients changed from 10 to 20, as reported by ClinicalTrials.gov.